Form 4: Hims & Hers Health Executive Michael Chi Exercises Stock Options and Sells Shares
SEC Filing
Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. exercised stock options and sold shares of Class A Common Stock on July 23 and 24, 2024, according to a Form 4 filing with the SEC.
Summary
- Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., engaged in transactions involving the company's Class A Common Stock.
- On July 23, 2024, Chi exercised stock options to acquire 7,500 shares at a price of $13.90 and sold the same amount at $22.00.
- On July 24, 2024, Chi exercised options to acquire 17,303 shares at $5.01 and sold the same amount at $22.25.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.
- Following these transactions, Chi directly owns 185,326 shares of Class A Common Stock.
- Chi also holds derivative securities, specifically stock options, for 328,766 shares.
Sentiment
Score: 5
Explanation: This Form 4 filing is a neutral event. It simply reports the transactions of a company insider exercising stock options and selling shares. The existence of a 10b5-1 plan suggests pre-planned and orderly transactions.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can be seen as a proactive measure to avoid insider trading concerns.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased number of shares sold into the market.
Key Dates
| Date | Description |
|---|---|
| March 1, 2024 | Date of adoption of Rule 10b5-1 trading plan |
| July 23, 2024 | Date of first reported transaction (option exercise and sale) |
| July 24, 2024 | Date of second reported transaction (option exercise and sale) |
| July 25, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.